Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.35 USD
Change Today +0.28 / 1.64%
Volume 110.1K
PETS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

petmed express inc (PETS) Snapshot

Open
$17.13
Previous Close
$17.07
Day High
$17.39
Day Low
$17.00
52 Week High
04/24/15 - $17.39
52 Week Low
10/20/14 - $12.07
Market Cap
351.6M
Average Volume 10 Days
180.8K
EPS TTM
$0.86
Shares Outstanding
20.3M
EX-Date
01/30/15
P/E TM
20.2x
Dividend
$0.68
Dividend Yield
3.92%
Current Stock Chart for PETMED EXPRESS INC (PETS)

Related News

No related news articles were found.

petmed express inc (PETS) Related Businessweek News

No Related Businessweek News Found

petmed express inc (PETS) Details

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats. Its non-prescription medications and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The company’s prescription medications comprise heartworm preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes. In addition, it sells food, beds, crates, stairs, strollers, and other pet supplies through its Website. The company offers its products under the Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution, and Rimadyl brands. It markets its products through television, online, and direct mail/print advertising campaigns, as well as through telephone contact center. The company primarily serves retail customers. PetMed Express, Inc. was founded in 1996 and is headquartered in Pompano Beach, Florida.

190 Employees
Last Reported Date: 05/27/14
Founded in 1996

petmed express inc (PETS) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $550.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $268.4K
Compensation as of Fiscal Year 2014.

petmed express inc (PETS) Key Developments

PetMed Express, Inc. Declares Quarterly Dividend, Payable on Feb. 13, 2015

PetMed Express, Inc. declared a quarterly dividend of $0.17 per share on the company's common stock. The dividend will be payable on Feb. 13, 2015, to shareholders of record at the close of business on Feb. 3, 2015.

PetMed Express, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

PetMed Express, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company's net income was $4.8 million, or $0.24 diluted per share compared to net income of $4.5 million, or $0.23 diluted per share, for the quarter ended December 31, 2013, an increase to net income of 5.6%. Net sales were $49.3 million, compared to $50.1 million for the quarter ended December 31, 2013, a decrease of 1.6%. Cash flow from operations was $29.5 million compared to $17.7 million for the quarter ended December 31, 2013. Income from operations was $7.67 million compared to $7.05 million reported a year ago. Income before provision for income taxes was $7.71 million compared to $7.09 million reported a year ago. Excluding a one-time charge for an IT-related discontinued project in the quarter ended September 30, 2014, net income for the nine months ended December 31, 2014 was $13.6 million, or $0.67 diluted per share, compared to net income of $13.4 million, or $0.67 diluted per share, for the nine months ended December 31, 2013, an increase to net income of 1.0%. The one-time IT-related discontinued project cost of $1.7 million was expensed in the September quarter. The after tax net impact of this charge was $1.1 million, or $0.05 diluted per share. There are no further charges expected in the future related to this discontinued project. Net sales were $179.4 million, compared to $184.8 million for the quarter ended December 31, 2013, a decrease of 2.9%. Net income was $12.50 million or $0.62 per diluted share compared to $13.45 million or $0.67 per diluted share reported a year ago. Net cash provided by operating activities was $29.53 million compared to $17.67 million reported a year ago. Purchases of property and equipment were $0.39 million compared to $0.039 million reported a year ago. Income from operations was $19.8 million compared to $21.08 million reported a year ago. Income before provision for income taxes was $19.93 million compared to $21.21 million reported a year ago. The decreases in sales were due to decreases in new order and reorder sales.

PetMed Express, Inc. to Report Q3, 2015 Results on Jan 20, 2015

PetMed Express, Inc. announced that they will report Q3, 2015 results at 8:30 AM, US Eastern Standard Time on Jan 20, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PETS:US $17.35 USD +0.28

PETS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abaxis Inc $63.62 USD +0.31
Heska Corp $30.42 USD +1.38
Nutrisystem Inc $20.00 USD +0.11
USANA Health Sciences Inc $128.29 USD +0.17
Vitamin Shoppe Inc $42.98 USD -0.15
View Industry Companies
 

Industry Analysis

PETS

Industry Average

Valuation PETS Industry Range
Price/Earnings 20.2x
Price/Sales 1.5x
Price/Book 4.7x
Price/Cash Flow 19.6x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PETMED EXPRESS INC, please visit www.1800petmeds.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.